NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









TippingPoint Biosciences

TippingPoint Biosciences

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.tippingpointbiosciences.com/

Last Round

Seed

Mar 31, 2026

Total Funding Raised

$7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

TippingPoint Biosciences is a biotechnology company that operates a drug discovery platform intended to identify treatments for diseases caused by defects in DNA packaging.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

drug discoveryepigeneticssmall moleculechromatinbiotechtherapeutic developmentprotein-protein interfacesDIPGpediatric brainstem tumorsdrug screeningfirst-in-class therapeuticscell-free systembiotech startupdrug pipelineprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TippingPoint Biosciences Comps

Public and private peers based on sector, stage, and business model.

TippingPoint Biosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TippingPoint Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 31, 2026
Pre SeedSep 4, 2024

Key People

Founding team and executive leadership

Laura Hsieh

CEO Founder

Founding Team

TippingPoint Biosciences Investors

Notable investors and investment history

TippingPoint Biosciences investors
InvestorRounds
Yuvaan Tiwari FoundationPre Seed
Freeflow VenturesSeed
WECAN Capital PartnersSeed
The Sontag FoundationPre Seed, Seed
BrightEdgePre Seed, Seed
Mission BioCapitalPre Seed
Pediatric Brain Tumor FoundationPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 6, 2026

    Monthly visitors increased 51% MoM.

  • Mar 31, 2026

    $5M seed round completed.

TippingPoint Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TippingPoint Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TippingPoint Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range7
Year Founded2022
Last FundingMar 31, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.